3rd Quarter - Report

SEWARD SQUARE GROUP for CAPITOL COUNSEL ON BEHALF OF RITE AID CORPORATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$20,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 21, 2014 $20,000 Replaced
3rd Quarter - Amendment (No Activity) Jul 21, 2020 $30,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54)

LobbyistCovered position, as disclosed
JAMIE FINCH —
JAMES PERICOLA —
RYAN THOMAS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medication therapy management, including related legislation HR 1024 & S 557, the Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act (P.L. 111-148/P.L. 111-152).

LobbyistCovered position, as disclosed
JAMIE FINCH —
JAMES PERICOLA —
RYAN THOMAS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1024 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.